Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alexander R Lyon

Showing results (51-60 of 267) with videos related to

Pageof 27
Sort By:
European Heart Journal. Cardiovascular Pharmacotherapy|January 19, 2019
Is P2Y12 inhibitor therapy associated with an increased risk of cancer?Christoph C Kaufmann, Alexander R Lyon, Johann Wojta, et al.
European Heart Journal|March 7, 2025
An update on the European Society of Cardiology Council of Cardio-OncologyTeresa López-Fernández, Peter van der Meer, Alexander R Lyon
Heart (British Cardiac Society)|August 26, 2017
Takotsubo syndrome: aetiology, presentation and treatmentKen Kato, Alexander R Lyon, Jelena-R Ghadri, et al.
European Heart Journal|June 7, 2024
Education in cardio-oncology: the next frontiersDimitrios Farmakis, Joerg Hermann, Alexander R Lyon, et al.
Seminars in Cardiothoracic and Vascular Anesthesia|September 9, 2006
A commentary on clinical trials in chronic heart failurePhilip A Poole-Wilson, Alexander R Lyon, Adam M Jacques
Cardiovascular Research|January 25, 2013
Spatial control of the βAR system in heart failure: the transverse tubule and beyondJulia Gorelik, Peter T Wright, Alexander R Lyon, et al.
Annals of Translational Medicine|June 6, 2015
Gene therapy for GM1 gangliosidosis: challenges of translational medicineCarl Hayward, Hitesh C Patel, Sanjay G Manohar, et al.
Presse Medicale (Paris, France : 1983)|November 23, 2025
Immunotherapy and the heart: Understanding the cardiovascular risks of immune checkpoint inhibitorsMaria Sol Andres, Maria Clara Llamedo, Sivatharshini Ramalingam, et al.
European Heart Journal Supplements : Journal of the European Society of Cardiology|March 5, 2021
Device closure for patent foramen ovale in patients with cryptogenic stroke: which patients should get it?Iris Parrini, Enrico Cecchi, Davide Forno, et al.
Journal of Molecular and Cellular Cardiology|February 14, 2013
Selective heart rate reduction with ivabradine slows ischaemia-induced electrophysiological changes and reduces ischaemia-reperfusion-induced ventricular arrhythmiasFu Siong Ng, Iqbal T Shadi, Nicholas S Peters, et al.
Pageof 27

Showing results (51-60 of 267) with videos related to

Sort By:
Pageof 27
European Heart Journal. Cardiovascular Pharmacotherapy|January 19, 2019
Is P2Y12 inhibitor therapy associated with an increased risk of cancer?Christoph C Kaufmann, Alexander R Lyon, Johann Wojta, et al.
European Heart Journal|March 7, 2025
An update on the European Society of Cardiology Council of Cardio-OncologyTeresa López-Fernández, Peter van der Meer, Alexander R Lyon
Heart (British Cardiac Society)|August 26, 2017
Takotsubo syndrome: aetiology, presentation and treatmentKen Kato, Alexander R Lyon, Jelena-R Ghadri, et al.
European Heart Journal|June 7, 2024
Education in cardio-oncology: the next frontiersDimitrios Farmakis, Joerg Hermann, Alexander R Lyon, et al.
Seminars in Cardiothoracic and Vascular Anesthesia|September 9, 2006
A commentary on clinical trials in chronic heart failurePhilip A Poole-Wilson, Alexander R Lyon, Adam M Jacques
Cardiovascular Research|January 25, 2013
Spatial control of the βAR system in heart failure: the transverse tubule and beyondJulia Gorelik, Peter T Wright, Alexander R Lyon, et al.
Annals of Translational Medicine|June 6, 2015
Gene therapy for GM1 gangliosidosis: challenges of translational medicineCarl Hayward, Hitesh C Patel, Sanjay G Manohar, et al.
Presse Medicale (Paris, France : 1983)|November 23, 2025
Immunotherapy and the heart: Understanding the cardiovascular risks of immune checkpoint inhibitorsMaria Sol Andres, Maria Clara Llamedo, Sivatharshini Ramalingam, et al.
European Heart Journal Supplements : Journal of the European Society of Cardiology|March 5, 2021
Device closure for patent foramen ovale in patients with cryptogenic stroke: which patients should get it?Iris Parrini, Enrico Cecchi, Davide Forno, et al.
Journal of Molecular and Cellular Cardiology|February 14, 2013
Selective heart rate reduction with ivabradine slows ischaemia-induced electrophysiological changes and reduces ischaemia-reperfusion-induced ventricular arrhythmiasFu Siong Ng, Iqbal T Shadi, Nicholas S Peters, et al.
Pageof 27